Vimarsana
Biggest News Aggregation in the World

Page 13 - Greg Seeto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Seeto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Seeto Today - Breaking & Trending Today

CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021 - Vimarsana News

CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021

“The CareDx sessions at the EFI meeting this year will tackle innovative subjects in the field of Immunogenetics and Transplantation, which will have great impact on improving patient care and transplant outcomes!” said Moheeb Al-Awwami, Director, Histocompatibility and Immunogenetics Laboratory, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. The second symposium, Donor-Derived Cell-Free DNA as Biomarker to Assess Active Rejection & Treatment Response in Kidney Allografts – Caner Su sal, University of Heidelberg, Germany Value of dd-cfDNA as a Surveillance Bi...

CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular - Vimarsana News

CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular

Published: Mar 17, 2021 SOUTH SAN FRANCISCO, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc.. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has acquired BFS Molecular S.R.L., a software company focused on NGS-based patient testing solutions. BFS Molecular brings extensive software and algorithm development capabilities for NGS transplant surveillance products that will add value to CareDx’s p...

CareDx Announces AlloID and Exclusive Partnership with IDbyDNA - Vimarsana News

CareDx Announces AlloID and Exclusive Partnership with IDbyDNA

CareDx Announces AlloID and Exclusive Partnership with IDbyDNA SOUTH SAN FRANCISCO, Calif. and SALT LAKE CITY, Jan. 07, 2021 — Today, CareDx, the leading partner in transplant care, and IDbyDNA, the company revolutionizing the use of precision metagenomics, announced an exclusive partnership focused on the development of metagenomic infectious disease testing specific to transplant patients. The companies will develop and commercialize AlloID, a tailored infectious disease testing solution that identifies more than 100 pathogens and drug resistance in viruses and bacteria, specific to org...

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 CentersAcquisition will build on CareDx's digital capabilities and continue deepening the moat with transplant centers - Vimarsana News

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 CentersAcquisition will build on CareDx's digital capabilities and continue deepening the moat with transplant centers

Published: Jan 08, 2021 SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc.. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has agreed to acquire TransChart LLC, an Ohio-based provider of electronic health record software supporting the needs of US transplant centers. The transaction is expected to close in January 2021. TransChart provides electronic medical record software to h...

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers - Vimarsana News

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers

Press release content from Globe Newswire. The AP news staff was not involved in its creation. CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers CareDx, Inc.January 8, 2021 GMT SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has agreed to acquire TransChart LLC, an Ohio-based provider of electronic h...

Source: apnews.com